AAA
Affinity Asset Advisors Portfolio holdings
AUM
$676M
This Quarter Return
-3.67%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$639M
AUM Growth
+$639M
(-0.21%)
Cap. Flow
+$95.5M
Cap. Flow
% of AUM
14.95%
Top 10 Holdings %
Top 10 Hldgs %
49.57%
Holding
109
New
20
Increased
27
Reduced
17
Closed
13
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$16.8M |
| 2 |
Travere Therapeutics
TVTX
|
$15.6M |
| 3 |
Protagonist Therapeutics
PTGX
|
$13.1M |
| 4 |
Nuvalent
NUVL
|
$12.4M |
| 5 |
Mineralys Therapeutics
MLYS
|
$11.9M |
Top Sells
| 1 |
Arvinas
ARVN
|
$12.1M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$10.3M |
| 3 |
Soleno Therapeutics
SLNO
|
$5.72M |
| 4 |
Arrowhead Research
ARWR
|
$5.64M |
| 5 |
Spyre Therapeutics
SYRE
|
$5.53M |
Sector Composition
| 1 | Healthcare | 90.82% |
| 2 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLYM
51
Climb Bio, Inc. Common Stock
CLYM
$151M
| $1.83M | 0.17% |
1,500,000
+1,000,000
| +200% | +$1.22M |
|
|
OKUR
52
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
| $1.69M | 0.16% |
394,159
+250,000
| +173% | +$1.08M |
|
53
Roivant Sciences
ROIV
$8.6B
| $1.51M | 0.14% |
+150,000
| New | +$1.51M |
|
54
Nkarta
NKTX
$149M
| $1.47M | 0.14% |
800,000
| – | – |
|
|
AVR
55
Anteris Technologies Global Corp. Common Stock
AVR
$148M
| $1.42M | 0.14% |
390,000
+90,000
| +30% | +$328K |
|
|
MBX
56
MBX Biosciences, Inc. Common Stock
MBX
$484M
| $1.29M | 0.12% |
+175,000
| New | +$1.29M |
|
|
THRD
57
DELISTED
Third Harmonic Bio
THRD
| $1.28M | 0.12% |
+370,000
| New | +$1.28M |
|
58
89bio
ETNB
$1.37B
| $1.27M | 0.12% |
+175,000
| New | +$1.27M |
|
|
ABVX
59
Abivax
ABVX
$6.2B
| $1.25M | 0.12% |
+200,000
| New | +$1.25M |
|
60
Olema Pharmaceuticals
OLMA
$432M
| $1.22M | 0.12% |
+325,000
| New | +$1.22M |
|
61
NextCure
NXTC
$13.3M
| $1.11M | 0.11% |
191,883
| – | – |
|
62
MeiraGTx Holdings
MGTX
$590M
| $1.02M | 0.1% |
+150,000
| New | +$1.02M |
|
63
Vaxcyte
PCVX
$4.17B
| $944K | 0.09% |
25,000
| – | – |
|
64
Viking Therapeutics
VKTX
$3.02B
| $604K | 0.06% |
+25,000
| New | +$604K |
|
65
Sutro Biopharma
STRO
$85.6M
| $490K | 0.05% |
+752,722
| New | +$490K |
|
66
Context Therapeutics
CNTX
$75.6M
| $404K | 0.04% |
660,589
-354,751
| -35% | -$217K |
|
67
Black Diamond Therapeutics
BDTX
$164M
| $388K | 0.04% |
250,000
-309,163
| -55% | -$479K |
|
|
RADX
68
Radiopharm Theranostics Limited American Depositary Shares
RADX
$42.8M
| $311K | 0.03% |
64,600
-91,571
| -59% | -$440K |
|
69
Zura Bio
ZURA
$132M
| $288K | 0.03% |
223,335
| – | – |
|
70
Compass Therapeutics
CMPX
$466M
| $249K | 0.02% |
+130,807
| New | +$249K |
|
71
Ovid Therapeutics
OVID
$94.6M
| $208K | 0.02% |
+667,516
| New | +$208K |
|
72
Repare Therapeutics
RPTX
$73.9M
| $197K | 0.02% |
200,000
+100,000
| +100% | +$98.6K |
|
|
ADGM
73
Adagio Medical Holdings, Inc Common Stock
ADGM
$25.1M
| $170K | 0.02% |
213,235
| – | – |
|
74
Omeros
OMER
$284M
| $81.9K | 0.01% |
9,958
| – | – |
|
|
ALLK
75
DELISTED
Allakos
ALLK
| $56.9K | 0.01% |
+250,000
| New | +$56.9K |
|